Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in CADASIL Patients with Cognitive Impairment
NCT00103948Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of donepezil in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), sponsored by Eisai Co., Ltd.. Started Feb 2005; status: completed.
02
Drugs
donepezil
03
Conditions
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Beyond the preview
Go deeper on NCT00103948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103948.